3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival
October 3, 2020
7,773
187
49
3.04%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Vinay Prasad Md Mph Episodes Around October 3, 2020
See what was published immediately before and after this episode.
2:44:073.13 COVID-19 and Schools, COVID-19 and Scott Atlas, and COVID-19 Policy
2:40:49Now Playing3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival
YouTube Description
as posted by the channelThis week we have a two-hour-long, far-ranging interview with Dr. John Ioannidis of Stanford University on, broadly, meta-research and COVID-19 - including his recent controversies. We end the episode with an interview with Dr. Mary-Elizabeth Percival of the University of Washington on her new paper out now in Haematologica: "Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility".
High-Grade Myeloid Neoplasms: doi.org/10.3324/haematol.2020.254938
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.